XML 43 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Theravance Respiratory Company, LLC (Details) - USD ($)
$ in Millions
3 Months Ended
Feb. 21, 2020
Mar. 31, 2022
Mar. 31, 2021
NDA Group      
Theravance Respiratory Company, LLC      
Percentage of equity interest   85.00%  
TRC      
Theravance Respiratory Company, LLC      
Percentage of equity interest   85.00%  
Percentage of economic interest 85.00%    
Royalty payments   $ 25.1 $ 16.5
Royalty expenses   0.2 $ 2.8
Amount due   35.6  
Long-term asset   94.1  
Net unrealized loss   0.4  
Payment received   $ 6.5